Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 5/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5084002 | 0.96 | SMN1; SMN2 (0.61) | SMN1; SMN2CYP1A2CYP2C9CYP2C19RAB9A | |
| Benzene SCHEMBL27873122 | 0.79 | CA1 (0.76) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL8993035 | 0.78 | SMN1; SMN2 (0.59) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL4643521 | 0.78 | LMNA (0.59) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL11408485 | 0.78 | KMT2A (0.76) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL4325829 | 0.78 | SMN1; SMN2 (0.73) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| Ethyl Benzoate SCHEMBL11224187 | 0.77 | LMNA (0.61) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL25340883 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL17940713 | 0.77 | SMN1; SMN2 (0.57) | SMN1; SMN2CYP1A2RAB9AGAANPC1 | |
| SCHEMBL10506176 | 0.77 | SMN1; SMN2 (0.57) | SMN1; SMN2CYP1A2RAB9AGAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937407-B1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2015-04-22 | — | — | EP | disclosed |
| US-8470982-B2 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8470982-B2 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8470982-B2 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET (DE) | 2013-06-25 | — | — | US | disclosed |
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2009-12-31 | — | — | US | disclosed |
| EP-1937407-A1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | Ludwig-Maximilians-Universität München (DE) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007026014-A1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007026014-A1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2007-03-08 | — | — | WO | disclosed |
| EP-1759765-A1 | Solutions of anhydrous lanthanide salts and its preparation | Ludwig-Maximilians-Universität München (DE) | 2007-03-07 | — | — | EP | disclosed |
| EP-1759765-A1 | Solutions of anhydrous lanthanide salts and its preparation | Ludwig-Maximilians-Universität München (DE) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | SLC39A3, AQP3, IKZF3 | SMN1; SMN2 4085/4885CYP1A2 3020/4885CYP2C9 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.